Intent to Sole Source - Tapestri Single-Cell DNA + Protein Reagent kit v3 & Tapestri® Single-Cell DNA Cartridge Kit v3

SOL #: NOI-OLAO-CC-26-004780Special Notice

Overview

Buyer

Health And Human Services
National Institutes Of Health
Bethesda, MD, 20892, United States

Place of Performance

Bethesda, MD

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
Apr 29, 2026
2
Action Date
May 8, 2026, 4:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The National Institutes of Health, Clinical Center (NIH-CC) intends to negotiate on a sole-source basis with Mission Bio for Tapestri Single-Cell DNA + Protein Reagent kits v3 and Tapestri® Single-Cell DNA Cartridge Kits v3. This acquisition supports the Center for Cellular Engineering (CCE) in streamlining CAR T cell manufacturing and clinical research through advanced single-cell analysis. This is a Notice of Intent, not a Request for Proposal.

Purpose & Scope

The CCE requires these specialized reagent kits for single-cell DNA and protein expression analysis, utilizing their existing Mission Bio Tapestri platform. This capability is critical for developing clinical lot release efficiency, supporting phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy. The kits enable simultaneous measurement of genotype and immunophenotype at the single-cell level, essential for understanding tumor phylogenies and patient stratification in cancer treatments. The scope includes procuring multi-type single-cell DNA and protein sequencing kits and reagents, ensuring minimum shelf life (3-6 months), and providing technical support.

Contract Details

  • Type: Intent to Sole Source (Special Notice)
  • Vendor: Mission Bio
  • Product: Tapestri Single-Cell DNA + Protein Reagent kit v3 (Part# MB03-0084) and Tapestri® Single-Cell DNA Cartridge Kit v3.
  • Estimated Value: $21,380.00
  • Period of Performance: Approximately May 28, 2026, to November 27, 2026 (6 months).
  • Delivery: Overnight, Monday through Thursday, to the Center for Cellular Engineering (CCE), NIH/CC, Bethesda, MD.
  • Special Requirements: Vendor must provide a report on cryopreserved patient cell transport, ensure temperature maintenance during shipment, and supply hard copies/PDFs of product proofs.

Set-Aside & Justification

This is a sole-source acquisition justified under 41 U.S.C. 253(c)(1) as implemented by FAR 6.302-1, citing only one responsible source. Mission Bio is identified as the only vendor capable of providing compatible reagent kits for the CCE's existing Tapestri instrument.

Response & Deadlines

This is not a Request for Proposal. However, all responsible sources that believe they can provide the required items may submit a capability statement via email to valerie.gregorio@nih.gov by 12:00 PM Eastern Standard Time on May 8, 2026. The subject line must reference NOI-OLAO-CC-26-004780. The Government will consider all responses received by the closing date.

People

Points of Contact

No contacts available

Files

Files

Download
Download
Download

Versions

Version 1Viewing
Special Notice
Posted: Apr 29, 2026
Intent to Sole Source - Tapestri Single-Cell DNA + Protein Reagent kit v3 & Tapestri® Single-Cell DNA Cartridge Kit v3 | GovScope